HealthMap

FDA Enforcement and Disease Claims

• Yes, the FDA actively issues Warning Letters to companies that make illegal drug claims for their products.
• Under the Federal Food, Drug, and Cosmetic Act, any product that is intended to diagnose, cure, mitigate, treat, or prevent diseases is legally considered a drug.
• When products sold as dietary supplements, foods, or alternative remedies are marketed with explicit or implicit disease-prevention claims without prior FDA approval, they are classified as misbranded or unapproved new drugs.

Target of Warning Letters

• The FDA routinely targets websites, social media, and product labels that promote substances for serious conditions.
• Common triggers for these warning letters include claims regarding:
• Cancer
• Heart disease
• Diabetes
• Infectious diseases (such as viral or bacterial infections)
• Neurological disorders

Consequences

• Receiving a warning letter requires the company to take prompt corrective action to remove the illegal claims.
• Failure to comply can lead to more severe regulatory actions, including:
• Product seizure
• Injunctions against the company and its owners
• Import detention at the border